FDA approved treatment for chronic kidney disease
On Apr. 30, 2021, the FDA approved AstraZeneca’s Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney…
On Apr. 30, 2021, the FDA approved AstraZeneca’s Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney…
On Apr. 30, 2021, the FDA revoked the emergency use authorization (EUA) of the Battelle CCDS Critical Care…
On Apr. 30, 2021, Moderna announced that the World Health Organization (WHO) had issued Emergency Use Listing (EUL)…
On Apr. 29, 2021, Lonza announced the expansion of its collaboration with Moderna to manufacture the drug substance…
On Apr. 29, 2021, the National Institutes of Health announced it was funding $29 million in additional grants…
On Apr. 29, 2021, researchers at the University of British Columbia announced a study published in Cell Reports…
On Apr. 29, 2021, scientists from several hospitals and research centers reported what happens in individual cells of…
On Apr. 29, 2021, Moderna announced it was making new funding commitments to increase supply at its owned…
On Apr. 29, 2021, Pfizer and BioNTech announced they had submitted a variation to the Conditional Marketing Authorization…
On Apr. 28, 2021, HHMI investigator Erich Jarvis and dozens of colleagues announced they had launched an ambitious…
On Apr. 28, 2021, XPhyto announce that it has delivered 2,000 of its rapid 25-minute PCR tests (モCovid-ID…
On Apr. 28, 2021, VBI Vaccines announced that preclinical data of VBIï¾’s enveloped virus-like particle (eVLP) vaccine candidate,…
On Apr. 28, 2021, Innovation Pharma announced that enrollment had surpassed 50 percent of the total targeted number…
On Apr. 28, 2021, Rockefeller University researchers announced the launch the Vertebrate Genomes Project, an ambitious initiative launched…
On Apr. 28, 2021, the Centers for Disease Control and Prevention (CDC) announced that both mRNA COVID-19 vaccines…
On Apr. 27, 2021, Merck announced the company had entered into non-exclusive voluntary licensing agreements for molnupiravir with…
On Apr. 27, 2021, AIM ImmunoTech announced that it had completed dosing of Cohort 2 in a Phase…
On Apr. 27, 2021, CerTest Biotec, along with BD announced the VIASURE SARS-CoV-2 (N1 + N2) Real Time…
COVID-19 and it’s naysayers are attacking Science and Reason. The defenders must suffer the slings and arrows from…
On Apr. 26, 2021, Gilead Sciences announced that in response to the rapid increase in COVID-19 cases in…
On Apr. 26, 2021, Moderna announced that it has entered into an agreement with Sanofi for fill/finish sterile…
On Apr. 23, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had awarded…
On Apr. 23, 2021, the NIH announced that a study assessing how people with immune system deficiencies or…
On Apr. 23, 2021, University of Oxford data from the COVID-19 Infection Survey was the first to show…
On Apr. 23, 2021, following a thorough safety review, including two meetings of the CDCï¾’s Advisory Committee on…
On Apr. 23, 2021, Inovio Pharma announced that it was planning for a predominantly ex-U.S. Phase 3 trial…
On Apr. 22, 2021, the NIH announced that a phase 3 trial to test the safety and efficacy…
On Apr. 22, 2021, RELIEF THERAPEUTICS and AdVita Lifescience announced that the first patient was expected to be…
On Apr. 22, 2021, the Strategic Advisory Group of Experts (SAGE) on Immunization annouced updated interim guidance on…
On Apr. 22, 2021, Quidel announced that it had completed a distribution and fulfillment agreement with McKesson to…